These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1000 related items for PubMed ID: 22784871

  • 1. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW.
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
    Davies KA, Ashwin H, Longshaw CM, Burns DA, Davis GL, Wilcox MH, EUCLID study group.
    Euro Surveill; 2016 Jul 21; 21(29):. PubMed ID: 27470194
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H, Obuch-Woszczatyński P, Lachowicz D, Wultańska D, Karpiński P, Młynarczyk G, van Dorp SM, Kuijper EJ, Polish Clostridium difficile Study Group.
    Euro Surveill; 2015 Jul 21; 20(38):. PubMed ID: 26536049
    [Abstract] [Full Text] [Related]

  • 7. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
    Suárez-Bode L, Barrón R, Pérez JL, Mena A.
    Anaerobe; 2019 Feb 21; 55():124-129. PubMed ID: 30550807
    [Abstract] [Full Text] [Related]

  • 8. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.
    Jamal W, Rotimi VO, Brazier J, Duerden BI.
    Anaerobe; 2010 Dec 21; 16(6):560-5. PubMed ID: 20887795
    [Abstract] [Full Text] [Related]

  • 9. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
    Balassiano IT, dos Santos-Filho J, Vital-Brazil JM, Nouér SA, Souza CR, Brazier JS, Ferreira Ede O, Domingues RM.
    Antonie Van Leeuwenhoek; 2011 Feb 21; 99(2):249-55. PubMed ID: 20623188
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
    Taori SK, Wroe A, Hardie A, Gibb AP, Poxton IR.
    J Infect; 2014 Aug 21; 69(2):134-44. PubMed ID: 24780765
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
    Novakova E, Stefkovicova M, Kopilec MG, Novak M, Kotlebova N, Kuijper E, Krutova M.
    Int J Infect Dis; 2020 Jan 21; 90():111-115. PubMed ID: 31707136
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J, Vernon J, Pilling S, Morris K, Nicholson S, Shearman S, Longshaw C, Wilcox MH, Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes Study Group.
    Clin Microbiol Infect; 2018 Jul 21; 24(7):724-731. PubMed ID: 29066403
    [Abstract] [Full Text] [Related]

  • 18. Effect of ribotype on all-cause mortality following Clostridium difficile infection.
    Inns T, Gorton R, Berrington A, Sails A, Lamagni T, Collins J, Perry J, Hill K, Magee J, Gould K.
    J Hosp Infect; 2013 Jul 21; 84(3):235-41. PubMed ID: 23759667
    [Abstract] [Full Text] [Related]

  • 19. Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period.
    Vanek J, Hill K, Collins J, Berrington A, Perry J, Inns T, Gorton R, Magee J, Sails A, Mullan A, Gould FK.
    J Hosp Infect; 2012 Jul 21; 81(3):209-12. PubMed ID: 22633277
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 50.